3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
5
Ovarian Neoplasms
2
Colorectal Neoplasms
2
Tuberous Sclerosis
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Pediatric Solid Tumor
1
Pancreatic Neoplasms
1
Neoplasms, Unknown Primary
1
Neoplasms
1
Lymphangioleiomyomatosis
1
Histiocytosis, Non-Langerhans-Cell
1
Histiocytosis, Langerhans-Cell
1
HER2-positive Breast Cancer
1
Early Detection of Cancer
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Castleman Disease
1
Breast Screening
1
Breast Neoplasms, Male
1
Brain Neoplasms
1
Anatomic Stage II Breast Cancer AJCC v8
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
pertuzumab
5
Trastuzumab
5
Docetaxel
3
tucatinib
2
pyrotinib
1
atezolizumab
1
Paclitaxel
1
Neoadjuvant Therapy
1
Injections
1
Genetic Testing
1
Carboplatin
1
Capecitabine
1
Blood Specimen Collection
1
Ado-Trastuzumab Emtansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
HER2-positive Breast Cancer
×
Genetic Testing
×
90 days
×
Clear all
NCT04638725
2026-06-04
SIGHER
Centre Paul Strauss
Recruiting
9,000 enrolled